The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab

PURPOSE: This prospective study was to investigate the value of [(11)C]-acetate PET and [(18)F]-FDG PET in the evaluation of hepatocellular carcinoma (HCC) before and after treatment with transarterial chemoembolization (TACE) and vascular endothelial growth factor (VEGF) antibody (bevacizumab). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuren, Peck-Radosavljevic, Markus, Ubl, Philipp, Wadsak, Wolfgang, Mitterhauser, Markus, Rainer, Eva, Pinter, Matthias, Wang, Hao, Nanoff, Christian, Kaczirek, Klaus, Haug, Alexander, Hacker, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537334/
https://www.ncbi.nlm.nih.gov/pubmed/28555333
http://dx.doi.org/10.1007/s00259-017-3724-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537334/
https://www.ncbi.nlm.nih.gov/pubmed/28555333
http://dx.doi.org/10.1007/s00259-017-3724-2

Ejemplares similares